ARCHIVES

FDA Approves Rituxan For CLL

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

March 30, 2007

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

October 27, 2006

In Brief: Schmidt Confers With Califano, Fredrickson On NCI director; Senate Hearing March 15-16

February 18, 1977

Paul Okunieff Named Director At UF Shands Cancer Center

October 16, 2009

Comments Invited On Centers Program

November 27, 1987

HHS, MB, OSTP Urge President To Veto Biomedical Research Authorization; Senate Pushes FTE Levels

November 1, 1985